Takeda Pharmaceutical (TAK) Equity Income (2025)
Takeda Pharmaceutical has reported Equity Income over the past 1 years, most recently at -$2.6 million for Q4 2025.
Takeda Pharmaceutical has reported Equity Income over the past 1 years, most recently at -$2.6 million for Q4 2025.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month